These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8751032)

  • 1. Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist.
    Goldberg MR; Lo MW; Bradstreet TE; Ritter MA; Höglund P
    Eur J Clin Pharmacol; 1995; 49(1-2):115-9. PubMed ID: 8751032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
    Ellis ML; Patterson JH
    Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
    Lo MW; Goldberg MR; McCrea JB; Lu H; Furtek CI; Bjornsson TD
    Clin Pharmacol Ther; 1995 Dec; 58(6):641-9. PubMed ID: 8529329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
    Ohtawa M; Takayama F; Saitoh K; Yoshinaga T; Nakashima M
    Br J Clin Pharmacol; 1993 Mar; 35(3):290-7. PubMed ID: 8471405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists: the prototype losartan.
    Schaefer KL; Porter JA
    Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazide.
    McCrea JB; Lo MW; Tomasko L; Lin CC; Hsieh JY; Capra NL; Goldberg MR
    J Clin Pharmacol; 1995 Dec; 35(12):1200-6. PubMed ID: 8750372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 9. Losartan: first of a new class of angiotensin antagonists for the management of hypertension.
    Carr AA; Prisant LM
    J Clin Pharmacol; 1996 Jan; 36(1):3-12. PubMed ID: 8932538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
    Burrell LM
    Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.
    Kong AN; Tomasko L; Waldman SA; Osborne B; Deutsch PJ; Goldberg MR; Bjornsson TD
    J Clin Pharmacol; 1995 Oct; 35(10):1008-15. PubMed ID: 8568008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms.
    Opsahl JA; Goldberg MR; Katz SA
    Am J Hypertens; 1995 Nov; 8(11):1090-8. PubMed ID: 8554732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of multiple-dose losartan, an angiotensin II receptor antagonist, in patients with essential hypertension.
    Sasaki M; Fujimura A; Harada K; Sunaga K; Ebihara A
    J Clin Pharmacol; 1996 May; 36(5):403-8. PubMed ID: 8739018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
    Munafo A; Christen Y; Nussberger J; Shum LY; Borland RM; Lee RJ; Waeber B; Biollaz J; Brunner HR
    Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin receptor antagonists: focus on losartan.
    Johnston CI
    Lancet; 1995 Nov; 346(8987):1403-7. PubMed ID: 7475826
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.
    Tsunoda K; Abe K; Hagino T; Omata K; Misawa S; Imai Y; Yoshinaga K
    Am J Hypertens; 1993 Jan; 6(1):28-32. PubMed ID: 8427658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan: the first angiotensin receptor antagonist in clinical use.
    Beevers DG
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dosage equivalents of AT1-receptor antagonists available in Germany].
    Dominiak P; Häuser W
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2315-8. PubMed ID: 14593575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.